116 related articles for article (PubMed ID: 38887684)
1. Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis.
Feng Y; Liang L; Jia W; Wang J; Xu C; Zhu D; Xu B; Zhao W; Ling X; Zhou Y; Kong L; Ding W
J Hepatocell Carcinoma; 2024; 11():1095-1112. PubMed ID: 38887684
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis.
Meng H; Li R; Xie Y; Mo Z; Zhai H; Zhang G; Liang G; Shi X; Zhou B
Int J Nanomedicine; 2023; 18():1677-1693. PubMed ID: 37020690
[TBL] [Abstract][Full Text] [Related]
3. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR-6165/IGF1R axis.
Shen D; Zhao H; Zeng P; Ge M; Shrestha S; Zhao W
Ann N Y Acad Sci; 2022 Jun; 1512(1):46-60. PubMed ID: 35199365
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma.
Xu G; Zhang P; Liang H; Xu Y; Shen J; Wang W; Li M; Huang J; Ni C; Zhang X; Zhu X
Cancer Cell Int; 2021 Apr; 21(1):212. PubMed ID: 33858418
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
[TBL] [Abstract][Full Text] [Related]
8. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27.
Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X
Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
[TBL] [Abstract][Full Text] [Related]
10. Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis.
Li Y; Zang H; Zhang X; Huang G
Cancer Manag Res; 2020; 12():7739-7751. PubMed ID: 32943922
[TBL] [Abstract][Full Text] [Related]
11. circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma.
Lin XH; Liu ZY; Zhang DY; Zhang S; Tang WQ; Li DP; Zhang F; Chen RX; Weng SQ; Xue RY; Dong L
Exp Hematol Oncol; 2022 Nov; 11(1):92. PubMed ID: 36348379
[TBL] [Abstract][Full Text] [Related]
12. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
13. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
Fu D; Ji Q; Wang C; Yu L; Yu R
Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
[TBL] [Abstract][Full Text] [Related]
14. Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis.
Fan W; Chen L; Wu X; Zhang T
Cancer Manag Res; 2021; 13():743-755. PubMed ID: 33531841
[TBL] [Abstract][Full Text] [Related]
15. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0097009 regulates proliferation, apoptosis, migration and invasion of hepatocellular carcinoma cells via miR-568/RNF38 axis.
Wu Z; Li H; Liu W; Huang R; Lin B
Bratisl Lek Listy; 2023; 124(3):228-238. PubMed ID: 36598315
[TBL] [Abstract][Full Text] [Related]
17. Circ_0006789 Promotes the Progression of Hepatocellular Carcinoma Cells
Cai Y; Jia Y; Yan P; Chang X; Li W; Cai B
Protein Pept Lett; 2022; 29(10):859-868. PubMed ID: 36017856
[TBL] [Abstract][Full Text] [Related]
18. CircSEC24A (hsa_circ_0003528) interference suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells via miR-421/MMP3 axis.
Zhang B; Zhou J
Bioengineered; 2022 Apr; 13(4):9049-9062. PubMed ID: 35400271
[TBL] [Abstract][Full Text] [Related]
19. Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
Wang K; Lu Q; Luo Y; Yu G; Wang Z; Lin J; Tan Z; Lao Y; Liu S; Yang H
Biol Direct; 2024 Jan; 19(1):4. PubMed ID: 38163874
[TBL] [Abstract][Full Text] [Related]
20. Circ_0046599 Promotes the Development of Hepatocellular Carcinoma by Regulating the miR-1258/RPN2 Network.
Fang Q; Liu H; Zhou A; Zhou H; Zhang Z
Cancer Manag Res; 2020; 12():6849-6860. PubMed ID: 32801909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
